Equillium Inc (EQ)
1.54
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
1.55
+0.01
(+0.65%)
After-Hours: 20:00
Equillium Free Cash Flow: -22.66M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -22.66M |
| December 31, 2023 | -21.83M |
| September 30, 2023 | 11.59M |
| June 30, 2023 | 0.448M |
| March 31, 2023 | -4.65M |
| December 31, 2022 | -9.012M |
| September 30, 2022 | -46.87M |
| June 30, 2022 | -40.85M |
| March 31, 2022 | -36.55M |
| December 31, 2021 | -32.14M |
| September 30, 2021 | -30.29M |
| Date | Value |
|---|---|
| June 30, 2021 | -28.32M |
| March 31, 2021 | -26.38M |
| December 31, 2020 | -24.83M |
| September 30, 2020 | -25.59M |
| June 30, 2020 | -25.21M |
| March 31, 2020 | -24.93M |
| December 31, 2019 | -23.02M |
| September 30, 2019 | -17.81M |
| June 30, 2019 | -14.76M |
| March 31, 2019 | -11.14M |
| December 31, 2018 | -7.561M |
Free Cash Flow Range, Past 5 Years
-46.87M
Minimum
Sep 2022
11.59M
Maximum
Sep 2023
-22.18M
Average
-24.88M
Median
Free Cash Flow Benchmarks
| Janux Therapeutics Inc | -53.26M |
| Mersana Therapeutics Inc | -173.92M |
| Vera Therapeutics Inc | -99.72M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -26.75M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.80M |
| Cash from Investing (Quarterly) | -2.831M |
| Free Cash Flow Per Share (Quarterly) | -0.2502 |
| Free Cash Flow to Equity (Quarterly) | -8.819M |
| Free Cash Flow to Firm (Quarterly) | -8.819M |
| Free Cash Flow Yield | -42.11% |